From: RETRACTED ARTICLE: The role of apatinib combined with paclitaxel (aluminum binding type) in platinum-resistant ovarian cancer
nab-P group
AP group
IC-50 (μmol/l)
24 h
45.53 ± 4.06
65.74 ± 8.33
48 h
20.88 ± 2.99
50.66 ± 4.96
72 h
8.77 ± 0.64
39.54 ± 6.62